spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

SMiís 5th Molecular Diagnostics Conference

9-11 July 2018
Holiday Inn Kensington Forum, London, UK

SMi is proud to announce their 5th Molecular Diagnostics conference. The event will take place in central London on Monday 9th and Tuesday 10th July 2018, along with two half-day post-conference workshops taking place on Wednesday 11th July 2018.

The global molecular diagnostics market is forecasted to reach over US$10 billion in the next three years, at a CAGR of 9.1% from 2016 to 2021*. In an ever-evolving universe of molecular diagnostics, it is vital to keep up with emerging and developing technology, products and applications. Furthermore, companies must comply to the constantly change regulatory environment and tackle the challenging process if implementing these regulations.

SMi welcomes you to explore the expanding market opportunities, the least diagnostics advancements and regulatory requirements at the 5th Molecular Diagnostics Conference.

This event is CPD accredited.

#SMiMolecularDx

Speaker Line-Up includes Matthew Albert, Nicholas Dale, Ana Alfirevic, Ashfaq Gilkar, Ben Courtney, Professor Kewal Jain, Matthew Albert, Miro Venturi.

Key themes for molecular diagnostics 2018:

  • Regulatory changes, challenges and outlook
  • Advances in laboratory technologies, including: biochips, nanotechnologies and proteomic technologies
  • Personalised medicine & pharmacogenomics
  • Diagnostic methods at the point of care
  • Molecular Diagnostics in Prenatal, Infectious Disease and Cancer

(*The Market Report can be found here: https://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-833.html.)

Who should attend?

Attendees will primarily be drawn from the following backgrounds/departments:

Molecular Diagnostic, Cancer Immunology, Immunobiology, Biomarkers, Radiation Oncology, Therapeutic Radiology, Translational Medicine, Translational Assays Technologies, Companion Diagnostics, Clinical Chemistry, Experimental Medicine and Diagnostics.

They will include Leads, Directors, Heads, Project Managers, Principal Investigators, Principal Scientists, Senior Scientists, Research Scientist, Professors, Researchers and Clinical Analysts, amongst others.

 
Print this page
Send to a friend
   
Banner of Bio Trinity_Events_Page on Samedan
spacer
Industry Events

ASGCT 22nd Annual Meeting

29 April - 2 May 2019, Washington Hilton, Washington, D.C

The 2019 ASGCT Annual Meeting is expected to be the largest in Society history, eclipsing the mark set by the 2018 meeting just last year. Join more than 3,500 researchers, clinicians, advocates, and industry leaders in discovering the latest science and technology surrounding gene and cell therapy.
More info >>

White Papers

The Importance of ADCC in Assessing Clinically Relevant Differences

Sartorius Stedim BioOutsource Ltd

Biosimilars have caused a revolution in the development of biologic drugs. The model for biosimilars is a combination of speed to market and low cost; these are fundamental to any biosimilar development project. The biosimilars pathway to approval is not always without difficulty, biosimilars are still relatively new, and as each new applicant is reviewed we are learning more and more about these molecules.
More info >>


News and Press Releases

Are you keeping up to date with changes to pharmaceutical laws and guidance?

The legal and regulatory environment affecting the pharmaceutical industry is in a period of unprecedented change. Are you keeping up with all these changes?
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement